Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.

As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.

The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.

The FDA first shared a warning about this issue back in April. Now, the agency has shared a critical update. 

New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy. 

Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.

As TAVR continues to gain popularity, researchers remain focused on discovering new ways to predict short- and long-term outcomes. One recent study, for example, explored the potential of AI-enabled imaging assessments. Another analysis focused on the CALLY index.

Makoto Hashimoto, MD, PhD, said robotic procedures are associated with a faster recovery time and many other potential benefits.

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.